Chelsey Leclear, MFT Psychologist - Family Medicare: Not Enrolled in Medicare Practice Location: 333 W 15th St, Liberal, KS 67901 Phone: 620-624-8171 Fax: 620-624-0114 |
Eva G Delay, LCP Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 333 W 15th St, Liberal, KS 67901 Phone: 620-624-8171 Fax: 620-624-0114 |
Ms. Keitha Eva Peters Psychologist Medicare: Not Enrolled in Medicare Practice Location: 333 W 15th St, Liberal, KS 67901 Phone: 620-624-8171 Fax: 620-624-0114 |
Mr. James J Karlan, LCP, LMLP Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 333 W 15th St, Liberal, KS 67901 Phone: 620-624-8171 Fax: 620-624-0114 |
Dr. Maria Lauralynn Noblejas, PSYD., LP Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 10 Plaza Dr, Liberal, KS 67901 Phone: 620-417-5230 Fax: 620-624-5227 |
Dr. Carolyn Lee Huddleston, PHD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 316 W 7th St, Liberal, KS 67901 Phone: 620-626-4508 Fax: 620-626-4508 |
News Archive
By studying specially bred mice with specific developmental and cognitive traits resembling those seen in schizophrenia, UC San Francisco researchers have provided new evidence that abnormal rhythmic activity in particular brain cells contributes to problems with learning, attention, and decision-making in individuals with that disorder.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced results from a 12-week, placebo-controlled Phase IIb study involving 79 patients with active rheumatoid arthritis ("RA") for its proprietary drug CF101, an A3 adenosine receptor ("A3AR") agonist.
According to the National Cancer Institute, almost 70,000 people ages 15-39 are diagnosed with cancer each year in the United States. Cancers in this adolescent and young adult (AYA) population differ quite a bit across this age span.
Endo Pharmaceuticals announced today that it has entered into a definitive agreement to acquire Qualitest Pharmaceuticals, a leading, privately held generics company in the U.S., for approximately $1.2 billion in cash.
› Verified 1 days ago